Ami Bavishi
Investor Relations Contact bij RALLYBIO CORPORATION
Actieve functies van Ami Bavishi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RALLYBIO CORPORATION | Investor Relations Contact | 18-01-2022 | - |
| Public Communications Contact | 18-01-2022 | - |
Loopbaan van Ami Bavishi
Eerdere bekende functies van Ami Bavishi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Investor Relations Contact | 02-01-2019 | - |
Opleiding van Ami Bavishi
| George Washington University | Graduate Degree |
| Duquesne University of The Holy Spirit | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Investor Relations Contact | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Beurs
- Insiders
- Ami Bavishi
- Ervaring
